On the contrary, CD8+ T cells among the tumor infiltrating CD45.1+ immune cells did not significantly increase in mice treated with the WT1 combination vaccine compared to those treated with the WT1 CTL vaccine alone. This evidence concerns the gene CD8A and neoplasm.